This decrease was accompanied by (and may indeed cause) the downregulation of CLL-specific gene signatures and a decrease in surface marker levels such as CD5 and CD19, together indicating a broad erosion of CLL cell identity. This evidence concerns the gene CD19 and B-cell chronic lymphocytic leukemia.